C Todd DeMarco
Overview
Explore the profile of C Todd DeMarco including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
660
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hurst J, Mohan A, Dalapati T, George I, Aquino J, Lugo D, et al.
Nat Commun
. 2025 Mar;
16(1):2383.
PMID: 40064870
Age is among the strongest risk factors for severe outcomes from SARS-CoV-2 infection. Here we describe upper respiratory tract (URT) and peripheral blood transcriptomes of 202 participants (age range of...
2.
Malewana R, Stalls V, May A, Lu X, Martinez D, Schafer A, et al.
bioRxiv
. 2024 Jan;
PMID: 38187726
Immunization with mRNA or viral vectors encoding spike with diproline substitutions (S-2P) has provided protective immunity against severe COVID-19 disease. How immunization with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)...
3.
Hurst J, Mohan A, Dalapati T, George I, Aquino J, Lugo D, et al.
medRxiv
. 2023 Aug;
PMID: 37577568
One Sentence Summary: Age is associated with distinct upper respiratory and peripheral blood transcriptional responses among children and adults with SARS-CoV-2 infection.
4.
Pahar B, Gray W, Fahlberg M, Grasperge B, Hunter M, Das A, et al.
Viruses
. 2022 Dec;
14(12).
PMID: 36560823
HIV vaccine mediated efficacy, using an expanded live attenuated recombinant varicella virus-vectored SIV rSVV-SIVgag/env vaccine prime with adjuvanted SIV-Env and SIV-Gag protein boosts, was evaluated in a female rhesus macaques...
5.
Li D, Martinez D, Schafer A, Chen H, Barr M, Sutherland L, et al.
Nat Commun
. 2022 Oct;
13(1):6309.
PMID: 36274085
Coronavirus vaccines that are highly effective against current and anticipated SARS-CoV-2 variants are needed to control COVID-19. We previously reported a receptor-binding domain (RBD)-sortase A-conjugated ferritin nanoparticle (scNP) vaccine that...
6.
Wang Z, Popowski K, Zhu D, Lopez de Juan Abad B, Wang X, Liu M, et al.
Nat Biomed Eng
. 2022 Jul;
6(7):791-805.
PMID: 35788687
The first two mRNA vaccines against infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that were approved by regulators require a cold chain and were designed to elicit systemic...
7.
Li D, Martinez D, Schafer A, Chen H, Barr M, Sutherland L, et al.
bioRxiv
. 2022 Feb;
PMID: 35118474
Coronavirus vaccines that are highly effective against SARS-CoV-2 variants are needed to control the current pandemic. We previously reported a receptor-binding domain (RBD) sortase A-conjugated ferritin nanoparticle (RBD-scNP) vaccine that...
8.
Li D, Edwards R, Manne K, Martinez D, Schafer A, Alam S, et al.
Cell
. 2021 Jul;
184(16):4203-4219.e32.
PMID: 34242577
SARS-CoV-2-neutralizing antibodies (NAbs) protect against COVID-19. A concern regarding SARS-CoV-2 antibodies is whether they mediate disease enhancement. Here, we isolated NAbs against the receptor-binding domain (RBD) or the N-terminal domain...
9.
Saunders K, Lee E, Parks R, Martinez D, Li D, Chen H, et al.
Nature
. 2021 May;
594(7864):553-559.
PMID: 33971664
Betacoronaviruses caused the outbreaks of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome, as well as the current pandemic of SARS coronavirus 2 (SARS-CoV-2). Vaccines that elicit protective...
10.
Saunders K, Lee E, Parks R, Martinez D, Li D, Chen H, et al.
bioRxiv
. 2021 Feb;
PMID: 33619494
Betacoronaviruses (betaCoVs) caused the severe acute respiratory syndrome (SARS) and Middle East Respiratory Syndrome (MERS) outbreaks, and now the SARS-CoV-2 pandemic. Vaccines that elicit protective immune responses against SARS-CoV-2 and...